Today's Information

Provided by: PACIFIC HOSPITAL SUPPLY CO., LTD.
SEQ_NO 5 Date of announcement 2022/06/15 Time of announcement 16:20:11
Subject
 The shareholders' meeting approved to release
the prohibition on new directors from participation in
competitive business.
Date of events 2022/06/15 To which item it meets paragraph 21
Statement
1.Date of the shareholders' meeting resolution:2022/06/15
2.Name and title of the managerial officer with permission
 to engage in competitive conduct:
(1)Director:Tang-Lung Hsu (Representative of Yi De Co., Ltd.)
(2)Independent Director:Adrain Chang
3.Items of competitive conduct in which the officer is
permitted to engage:
(1)Director:Tang-Lung Hsu (Representative of Yi De Co., Ltd.)
   Chairman of Ke Yue Co., Ltd.
   Chairman of Yi De Co., Ltd.
   Chairman of Yi Sheng Co., Ltd.
   Chairman of Catcher Medtech Co., Ltd.
   Chairman of Smart eCare Inc.
   Vice President of Catcher Technology Co., Ltd.
(2)Independent Director:Adrain Chang
   Advisor of B Current Impact Investment Inc.
   Independent Director of Thai Kin Co., Ltd.
   Independent Director of M-Power Information Co., Ltd.
   Board Director of DataYoo Application Co., Ltd.
   Board Director of BDFF CO., LTD.
4.Period of permission to engage in the competitive conduct:
During the period of serving as the Company's directors.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):The resolution is adopted by a large majority of two thirds of
the voting powers of the shareholders present at the shareholders' meeting
who represent a majority of the total number of issued shares.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter "N/A" below):NA
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:NA
8.Address of the mainland China enterprise:NA
9.Operations of the mainland China enterprise:NA
10.Impact on the company's finance and business:NA
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:NA
12.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Pacific Hospital Supply Co. Ltd. published this content on 15 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 June 2022 08:32:07 UTC.